Abstract

ABSTRACT Conducting both inhalatory and dermal samplings are crucial for chemicals, such as polycyclic aromatic hydrocarbons (PAHs), which are known with chronic dermal and inhalatory health effects. The present study is the first one set out for conducting both PAH inhalatory and dermal exposure assessments simultaneously for electric arc furnace (EAF) workers in an iron and steelmaking industry. The results were further used to assess the health risks posed on workers. Finally, risk-based control strategies were suggested. Three similar exposure groups (SEGs) of the melting, ladling, and casting were selected for conducting personal samplings. A total of 15 and 120 samples were collected for assessing workers’ inhalatory and dermal PAH exposures, respectively. Results show that the inhalatory gas-phase PAH exposure levels (2.17 × 104–1.52 × 105 ng m–3) were consistently higher than that of particle-phase (2.73 × 103–6.76 × 103 ng m–3) in all selected exposure groups. The mean inhalatory exposure concentrations of the melting and casting workers (2.84 × 104–3.32 × 104 ng m–3) were higher, but ladling workers (1.58 × 105 ng m–3) were lower, than the time-weighted average permissible exposure level (PEL-TWA) regulated in Taiwan (1.00 × 105 ng m–3). The estimated lifetime excessive lung cancer risks for the latter (2.09 × 10–3) were lower than that of the former (3.43 × 10-3–8.84 × 10–3), they were all higher than the significant risk (10–3) defined by the US Supreme Court. The mean whole-body total PAH dermal exposure levels were 2.84 × 105–7.45 × 105 ng day–1, and those body surfaces uncovered by clothes were found with higher exposure levels. Since the estimated lifetime excessive skin cancer risks (7.74 × 10–5–1.62 × 10–4) were lower than of the lung cancer risk, which indicates that the control of workers' inhalatory exposures is more important than that of dermal exposures. The installation of effective ventilation systems and the use of proper personal respiratory protection equipment are recommended for the abatement of risks posed on workers associated with PAH exposures.

Highlights

  • The electric arc furnace (EAF) is widely used in the steel and iron manufacturing industry producing ∼1,600 million tons yr–1 steel worldwide (World Steel Association, 2017)

  • The present study shows that mean inhalatory exposure levels for melting and casting workers (= 2.84 × 104 ng m–3 and 3.32 × ng m–3) were lower than the time-weighted average permissible exposure level (PEL-TWA) regulated in Taiwan for polycyclic aromatic hydrocarbons (PAHs) (= 1.00 × ng m–3)

  • We found that the inhalatory gas-phase PAH exposure level was much higher than that of particle-phase

Read more

Summary

INTRODUCTION

The electric arc furnace (EAF) is widely used in the steel and iron manufacturing industry producing ∼1,600 million tons yr–1 steel worldwide (World Steel Association, 2017). It can be expected that conducting PAH exposure and health-risk assessments for EAF workers would be of importance to the steel and iron manufacturing industry before initiating effective exposure control strategies. It is true that a recent study has been conducted to assess inhalatory PAH exposure concentrations for EAF workers at different worksites (Aries et al, 2008) Their dermal exposures and inherent health risks have never been assessed. Considering long-term exposures to PAHs might result in workers with excessive respiratory and dermal cancer risks (Diggs et al, 2012; Wells et al, 2010; ATSDR, 1995; Srogi, 2007; Kuo et al, 2003), the present study was set out for conducting both inhalatory and dermal exposure and health-risk assessments for EAF workers simultaneously. The results obtained from this study would be beneficial to the steel and iron industry to initiate effective control strategies

Personal Inhalable and Dermal PAH Exposure Samplings
Sample Analyses
Calculating BaP equivalent concentrations
Calculating personal dermal PAH exposure concentrations
Heath-risk assessment
Personal Inhalatory PAH Exposures
Personal Dermal PAH Exposures
Health-risks Associated with Inhalatory and Dermal PAH Exposures
Control Strategies
CONCLUSIONS

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.